Markers of inflammation and endothelial dysfunction are also evident after cisplatin-based chemotherapy, including Von Willebrand factor, fibrinogen, tissue-type plasminogen activator, and high-sensitivity C-reactive protein33,34. Here, PLAT is linked to endothelial dysfunction.